Buck Wealth Strategies, LLC Abb Vie Inc. Transaction History

Buck Wealth Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $39,943 - $46,240	299 Added 0.8%	37,907 $5.65 Million
Q2 2023 Nov 06, 2023	BUY	$132.51 - $164.9 $574,033 - $714,346	4,332 Added 13.02%	37,608 $5.07 Billion
Q1 2023 Nov 06, 2023	SELL	$144.61 - $166.54 $241,932 - $278,621	-1,673 Reduced 4.79%	33,276 $5.3 Billion
Q3 2022 Oct 30, 2023	BUY	$134.21 - $153.93 $4.69 Million - $5.38 Million	34,949 New	34,949 $5.21 Billion

3,795

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $353B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Buck Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Buck Wealth Strategies, LLC with notifications on news.